Latest Breaking News On - Second favorable interim award received - Page 1 : comparemela.com

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2023..

United statesIain brownKatie joyceSandy coombsExchange commissionAlkermes incBiogen ma incDrug administrationAlkermes pharma irelandFirst quarter revenuesReflect strong performanceProprietary product portfolioPlanned separationOncology business expectedSecond halfSecond favorable interim award received